{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:32:48Z","timestamp":1784547168724,"version":"3.55.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T00:00:00Z","timestamp":1674691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["15FTF25890062"],"award-info":[{"award-number":["15FTF25890062"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","award":["IISP-57335"],"award-info":[{"award-number":["IISP-57335"]}],"id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R56HL157367-01A1"],"award-info":[{"award-number":["1R56HL157367-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL-064750"],"award-info":[{"award-number":["HL-064750"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.biopha.2023.114310","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T19:33:25Z","timestamp":1675193605000},"page":"114310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["SGLT2 inhibitor ertugliflozin decreases elevated intracellular sodium, and improves energetics and contractile function in diabetic cardiomyopathy"],"prefix":"10.1016","volume":"160","author":[{"given":"Dominique","family":"Croteau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Baka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huamei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan M.","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuzhong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Panagia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Pimentel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Balschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson S.","family":"Colucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7498-7694","authenticated-orcid":false,"given":"Ivan","family":"Luptak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.114310_bib1","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","article-title":"Basic mechanisms of diabetic heart disease","volume":"126","author":"Ritchie","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2023.114310_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112463","article-title":"Current status on the therapeutic strategies for heart failure and diabetic cardiomyopathy","volume":"145","author":"Kim","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2023.114310_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijcard.2021.03.077","article-title":"Effects of SGLT2 inhibitors on cardiovascular, renal, and major safety outcomes in heart failure: a meta-analysis of randomized controlled trials","volume":"332","author":"Li","year":"2021","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.biopha.2023.114310_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112169","article-title":"Effects of SGLT2 inhibitors on ion homeostasis and oxidative stress associated mechanisms in heart failure","volume":"143","author":"Gager","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2023.114310_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112515","article-title":"Empagliflozin reduces oxidative stress through inhibition of the novel inflammation\/NHE\/[Na+]c\/ROS-pathway in human endothelial cells","volume":"146","author":"Uthman","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2023.114310_bib6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/cvr\/cvx149","article-title":"Cardiac effects of SGLT2 inhibitors: the sodium hypothesis","volume":"114","author":"Bertero","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2023.114310_bib7","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s00125-016-4134-x","article-title":"Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+\/H+ exchanger in rats and rabbits","volume":"60","author":"Baartscheer","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2023.114310_bib8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/01.CIR.0000023042.50192.F4","article-title":"Rate dependence of [Na+]i and contractility in nonfailing and failing human myocardium","volume":"106","author":"Pieske","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2023.114310_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002183","article-title":"Intracellular Na+ concentration ([Na+]i) is elevated in diabetic hearts due to enhanced Na+-glucose cotransport","volume":"4","author":"Lambert","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.biopha.2023.114310_bib10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ehf2.12003","article-title":"The late sodium current in heart failure: pathophysiology and clinical relevance","volume":"1","author":"Horvath","year":"2014","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.biopha.2023.114310_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-3-642-41588-3_7","article-title":"The role of late ina in development of cardiac arrhythmias","volume":"221","author":"Antzelevitch","year":"2014","journal-title":"Handb. Exp. Pharm."},{"key":"10.1016\/j.biopha.2023.114310_bib12","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1161\/CIRCULATIONAHA.121.053350","article-title":"Cardiac late sodium channel current is a molecular target for the sodium\/glucose cotransporter 2 inhibitor empagliflozin","volume":"143","author":"Philippaert","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2023.114310_bib13","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1161\/CIRCULATIONAHA.121.057237","article-title":"Empagliflozin Reverses late Na+ current enhancement and cardiomyocyte proarrhythmia in a translational murine model of heart failure with preserved ejection fraction","volume":"145","author":"Hegyi","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2023.114310_bib14","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1161\/HYPERTENSIONAHA.113.01744","article-title":"Arterial stiffening precedes systolic hypertension in diet-induced obesity","volume":"62","author":"Weisbrod","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2023.114310_bib15","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019995","article-title":"Effects of sodium-glucose linked transporter 2 inhibition with ertugliflozin on mitochondrial function, energetics, and metabolic gene expression in the presence and absence of diabetes mellitus in mice","volume":"10","author":"Croteau","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.biopha.2023.114310_bib16","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1161\/CIRCULATIONAHA.111.067801","article-title":"The polyphenols resveratrol and S17834 prevent the structural and functional sequelae of diet-induced metabolic heart disease in mice","volume":"125","author":"Qin","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2023.114310_bib17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.yjmcc.2018.01.017","article-title":"Decreased ATP production and myocardial contractile reserve in metabolic heart disease","volume":"116","author":"Luptak","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.biopha.2023.114310_bib18","doi-asserted-by":"crossref","first-page":"H2437","DOI":"10.1152\/ajpheart.00534.2003","article-title":"Energy requirements for the Na+ gradient in the oxygenated isolated heart: effect of changing the free energy of ATP hydrolysis","volume":"285","author":"Jansen","year":"2003","journal-title":"Am. J. Physiol. - Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2023.114310_bib19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/mrm.1910320206","article-title":"Intracellular and extracellular spaces and the direct quantification of molar intracellular concentrations of phosphorus metabolites in the isolated rat heart using 31P NMR spectroscopy and phosphonate markers","volume":"32","author":"Clarke","year":"1994","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.biopha.2023.114310_bib20","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1038\/s41467-020-18160-x","article-title":"Intracellular sodium elevation reprograms cardiac metabolism","volume":"11","author":"Aksentijevi\u0107","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2023.114310_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.661297","article-title":"Sex differences of the diabetic heart","volume":"12","author":"Fourny","year":"2021","journal-title":"Front. Physiol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223000987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223000987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:47:52Z","timestamp":1776772072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223000987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":21,"alternative-id":["S0753332223000987"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114310","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SGLT2 inhibitor ertugliflozin decreases elevated intracellular sodium, and improves energetics and contractile function in diabetic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114310","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114310"}}